DEO Diageo | $86.30 -1.4% | 3/7/2018 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Diageo (NYSE:DEO) on 3/7/2018 |
BNPQY BNP Paribas | $56.33 -1.3% | 2/13/2018 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of BNP Paribas (OTCMKTS:BNPQY) on 2/13/2018 |
AZN Astrazeneca | $166.09 -0.3% | 9/6/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Astrazeneca (NYSE:AZN) on 9/6/2017 |
AZN AstraZeneca | £125.23 -0.2% | 9/6/2017 | | Upgrade | GBX 5,000 ➝ GBX 5,738 | Neutral ➝ Buy | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 9/6/2017 |
CRRFY Carrefour | $3.81 +1.9% | 8/31/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Carrefour (OTCMKTS:CRRFY) on 8/31/2017 |
CRRFY Carrefour | $3.81 +1.9% | 8/31/2017 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Carrefour (OTCMKTS:CRRFY) on 8/31/2017 |
CTTAY Continental | $7.93 -0.7% | 7/18/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Continental (OTCMKTS:CTTAY) on 7/18/2017 |
PHG Koninklijke Philips | $25.11 +0.6% | 6/21/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Koninklijke Philips (NYSE:PHG) on 6/21/2017 |
IBDRY Iberdrola | $92.64 -0.6% | 6/8/2017 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Iberdrola (OTCMKTS:IBDRY) on 6/8/2017 |
BCS Barclays | $24.61 -0.8% | 5/4/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Barclays (NYSE:BCS) on 5/4/2017 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
CABGY Carlsberg AS | $25.78 -2.0% | 3/29/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Carlsberg AS (OTCMKTS:CABGY) on 3/29/2017 |
NWG NatWest Group | $18.35 -0.8% | 3/17/2017 | | Upgrade | | Reduce ➝ Buy | 00.00% | View details for Natixis rating of NatWest Group (NYSE:NWG) on 3/17/2017 |
DB Deutsche Bank Aktiengesellschaft | $36.06 -1.4% | 3/6/2017 | | Reiterated Rating | | Reduce | 00.00% | View details for Natixis rating of Deutsche Bank Aktiengesellschaft (NYSE:DB) on 3/6/2017 |
DBVT DBV Technologies | $11.64 +0.7% | 2/17/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of DBV Technologies (NASDAQ:DBVT) on 2/17/2017 |
VLEEY Valeo | $8.30 -2.9% | 2/17/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Valeo (OTCMKTS:VLEEY) on 2/17/2017 |
SNY Sanofi | $41.18 +0.2% | 2/9/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Sanofi (NASDAQ:SNY) on 2/9/2017 |
ABBNY ABB | $96.29 -0.8% | 2/8/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of ABB (OTCMKTS:ABBNY) on 2/8/2017 |
NOK Nokia | $10.10 -2.8% | 1/13/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Nokia (NYSE:NOK) on 1/13/2017 |
HSBA HSBC | GBX 1,523.46 +0.6% | 11/17/2016 | | Reiterated Rating | GBX 478 ➝ GBX 672 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 11/17/2016 |
HSBC HSBC | $101.18 +0.2% | 11/17/2016 | | Upgrade | | Reduce ➝ Neutral | 00.00% | View details for Natixis rating of HSBC (NYSE:HSBC) on 11/17/2016 |
WPP WPP | GBX 385.80 -2.0% | 11/1/2016 | | Boost Price Target | GBX 1,600 ➝ GBX 1,650 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 11/1/2016 |
GSK GSK | GBX 1,860 +0.5% | 10/27/2016 | | Reiterated Rating | GBX 1,750 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 10/27/2016 |
LLOY Lloyds Banking Group | GBX 108.10 -0.6% | 10/27/2016 | | Reiterated Rating | GBX 56 | Neutral | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 10/27/2016 |
ERIC Ericsson | $9.42 -1.2% | 10/13/2016 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Ericsson (NASDAQ:ERIC) on 10/13/2016 |
SAN Banco Santander | $14.25 -1.2% | 10/11/2016 | | Upgrade | | Reduce ➝ Buy | 00.00% | View details for Natixis rating of Banco Santander (NYSE:SAN) on 10/11/2016 |
BUD Anheuser-Busch InBev SA/NV | $77.10 -1.2% | 8/3/2016 | | Upgrade | | Reduce ➝ Neutral | 00.00% | View details for Natixis rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 8/3/2016 |
NWG NatWest Group | $18.35 -0.8% | 7/18/2016 | | Downgrade | | Neutral ➝ Reduce | 00.00% | View details for Natixis rating of NatWest Group (NYSE:NWG) on 7/18/2016 |
FERG Ferguson | GBX 234.33
| 6/2/2016 | | Reiterated Rating | GBX 3,900 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 6/2/2016 |
PSON Pearson | GBX 1,202.50 -1.3% | 5/18/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 5/18/2016 |
CCL Carnival Co. & | GBX 1,903.50
| 3/31/2016 | | Boost Price Target | GBX 4,200 ➝ GBX 4,300 | Buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 3/31/2016 |
ABBNY ABB | $96.29 -0.8% | 3/28/2016 | | Upgrade | $25.50 | Neutral ➝ Buy | 00.00% | View details for Natixis rating of ABB (OTCMKTS:ABBNY) on 3/28/2016 |
ASML ASML | $1,771.41 +1.6% | 3/28/2016 | | Lower Price Target | $83.00 ➝ $80.00 | Buy | 00.00% | View details for Natixis rating of ASML (NASDAQ:ASML) on 3/28/2016 |
AZN AstraZeneca | £125.23 -0.2% | 3/24/2016 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 3/24/2016 |
PSON Pearson | GBX 1,202.50 -1.3% | 3/24/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 3/24/2016 |
PSON Pearson | GBX 1,202.50 -1.3% | 3/17/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 3/17/2016 |
WTB Whitbread | GBX 2,367 +0.8% | 3/15/2016 | | Reiterated Rating | GBX 4,000 | Neutral | 00.00% | View details for Natixis rating of Whitbread (LON:WTB) on 3/15/2016 |
LLOY Lloyds Banking Group | GBX 108.10 -0.6% | 3/11/2016 | | Reiterated Rating | GBX 85 | Buy | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 3/11/2016 |
PSON Pearson | GBX 1,202.50 -1.3% | 3/8/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 3/8/2016 |
WPP WPP | GBX 385.80 -2.0% | 3/7/2016 | | Boost Price Target | GBX 1,400 ➝ GBX 1,410 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 3/7/2016 |
BARC Barclays | GBX 464.10 +0.4% | 3/3/2016 | | Reiterated Rating | GBX 212 | Buy | 00.00% | View details for Natixis rating of Barclays (LON:BARC) on 3/3/2016 |
Trump goes "all-in" on Grand Canyon energy breakthrough (Ad) A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. See the ticker behind this Grand Canyon energy breakthrough now |
PSON Pearson | GBX 1,202.50 -1.3% | 2/29/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 2/29/2016 |
LLOY Lloyds Banking Group | GBX 108.10 -0.6% | 2/26/2016 | | Reiterated Rating | GBX 85 | Buy | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 2/26/2016 |
STAN Standard Chartered | GBX 2,322 +0.4% | 2/25/2016 | | Lower Price Target | GBX 522 ➝ GBX 374 | Neutral | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 2/25/2016 |
AZN AstraZeneca | £125.23 -0.2% | 2/24/2016 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 2/24/2016 |
WPP WPP | GBX 385.80 -2.0% | 2/17/2016 | | Reiterated Rating | GBX 1,400 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 2/17/2016 |
LRLCY L'Oreal | $88.11 +0.6% | 2/9/2016 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of L’Oreal (OTCMKTS:LRLCY) on 2/9/2016 |
AZN AstraZeneca | £125.23 -0.2% | 1/26/2016 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 1/26/2016 |
WPP WPP | GBX 385.80 -2.0% | 1/22/2016 | | Downgrade | GBX 1,400 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 1/22/2016 |
HSBA HSBC | GBX 1,523.46 +0.6% | 1/20/2016 | | Downgrade | GBX 487 ➝ GBX 433 | Reduce | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 1/20/2016 |
LLOY Lloyds Banking Group | GBX 108.10 -0.6% | 1/20/2016 | | Reiterated Rating | GBX 85 | Buy | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 1/20/2016 |
GSK GSK | GBX 1,860 +0.5% | 1/13/2016 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 1/13/2016 |
CCL Carnival Co. & | GBX 1,903.50
| 12/21/2015 | | Boost Price Target | GBX 3,800 ➝ GBX 4,200 | Buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 12/21/2015 |
HSBA HSBC | GBX 1,523.46 +0.6% | 12/21/2015 | | Reiterated Rating | GBX 487 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 12/21/2015 |
STAN Standard Chartered | GBX 2,322 +0.4% | 12/10/2015 | | Upgrade | GBX 522 | Neutral | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 12/10/2015 |
HSBA HSBC | GBX 1,523.46 +0.6% | 12/8/2015 | | Reiterated Rating | GBX 487 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 12/8/2015 |
CPG Compass Group | GBX 29.54 +0.3% | 12/4/2015 | | Boost Price Target | GBX 1,070 ➝ GBX 1,100 | Neutral | 00.00% | View details for Natixis rating of Compass Group (LON:CPG) on 12/4/2015 |
PSON Pearson | GBX 1,202.50 -1.3% | 12/4/2015 | | Reiterated Rating | GBX 1,400 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 12/4/2015 |
STAN Standard Chartered | GBX 2,322 +0.4% | 12/3/2015 | | Reiterated Rating | GBX 548 | Reduce | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 12/3/2015 |
DGE Diageo | GBX 1,659.50 +1.2% | 12/1/2015 | | Reiterated Rating | GBX 2,060 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 12/1/2015 |
PSON Pearson | GBX 1,202.50 -1.3% | 11/25/2015 | | Reiterated Rating | GBX 1,400 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 11/25/2015 |
CPG Compass Group | GBX 29.54 +0.3% | 11/18/2015 | | Reiterated Rating | GBX 1,070 | Neutral | 00.00% | View details for Natixis rating of Compass Group (LON:CPG) on 11/18/2015 |
AZN AstraZeneca | £125.23 -0.2% | 11/12/2015 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 11/12/2015 |
FERG Ferguson | GBX 234.33
| 11/11/2015 | | Reiterated Rating | GBX 3,900 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 11/11/2015 |
ECIFY Electricité de France | $2.55
| 11/9/2015 | | Reiterated Rating | $20.00 ➝ $19.00 | Neutral | 00.00% | View details for Natixis rating of Electricité de France (OTCMKTS:ECIFY) on 11/9/2015 |
STAN Standard Chartered | GBX 2,322 +0.4% | 11/6/2015 | | Reiterated Rating | GBX 548 | Reduce | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 11/6/2015 |
AZN AstraZeneca | £125.23 -0.2% | 11/4/2015 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 11/4/2015 |
GSK GSK | GBX 1,860 +0.5% | 11/4/2015 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 11/4/2015 |
HSBA HSBC | GBX 1,523.46 +0.6% | 11/3/2015 | | Lower Price Target | GBX 495 ➝ GBX 487 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 11/3/2015 |
BARC Barclays | GBX 464.10 +0.4% | 10/30/2015 | | Lower Price Target | GBX 292 ➝ GBX 283 | Buy | 00.00% | View details for Natixis rating of Barclays (LON:BARC) on 10/30/2015 |
WPP WPP | GBX 385.80 -2.0% | 10/27/2015 | | Lower Price Target | GBX 1,750 ➝ GBX 1,660 | Buy | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 10/27/2015 |
GSK GSK | GBX 1,860 +0.5% | 10/26/2015 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 10/26/2015 |
AZN AstraZeneca | £125.23 -0.2% | 10/25/2015 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 10/25/2015 |
IHG InterContinental Hotels Group | GBX 158.44 +0.9% | 10/21/2015 | | Reiterated Rating | GBX 2,600 | Neutral | 00.00% | View details for Natixis rating of InterContinental Hotels Group (LON:IHG) on 10/21/2015 |
WTB Whitbread | GBX 2,367 +0.8% | 10/21/2015 | | Reiterated Rating | GBX 5,050 | Neutral | 00.00% | View details for Natixis rating of Whitbread (LON:WTB) on 10/21/2015 |
AZN AstraZeneca | £125.23 -0.2% | 10/19/2015 | | Lower Price Target | GBX 4,628 ➝ GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 10/19/2015 |
PSON Pearson | GBX 1,202.50 -1.3% | 10/19/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 10/19/2015 |
BCS Barclays | $24.61 -0.8% | 10/16/2015 | | Initiated Coverage | | Buy | 00.00% | View details for Natixis rating of Barclays (NYSE:BCS) on 10/16/2015 |
ING ING Group | $36.38 -0.5% | 10/9/2015 | | Initiated Coverage | | Buy | 00.00% | View details for Natixis rating of ING Group (NYSE:ING) on 10/9/2015 |
AZN AstraZeneca | £125.23 -0.2% | 10/7/2015 | | Reiterated Rating | GBX 4,628 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 10/7/2015 |
GSK GSK | GBX 1,860 +0.5% | 10/7/2015 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 10/7/2015 |
VOD Vodafone Group Public | GBX 126.73 +1.0% | 10/5/2015 | | Reiterated Rating | GBX 224 | Neutral | 00.00% | View details for Natixis rating of Vodafone Group Public (LON:VOD) on 10/5/2015 |
FERG Ferguson | GBX 234.33
| 9/30/2015 | | Lower Price Target | GBX 4,300 ➝ GBX 3,900 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 9/30/2015 |
WPP WPP | GBX 385.80 -2.0% | 9/30/2015 | | Reiterated Rating | GBX 1,750 | Buy | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 9/30/2015 |
DEO Diageo | $86.30 -1.4% | 9/24/2015 | | Reiterated Rating | | Buy | 00.00% | View details for Natixis rating of Diageo (NYSE:DEO) on 9/24/2015 |
DGE Diageo | GBX 1,659.50 +1.2% | 9/24/2015 | | Lower Price Target | GBX 2,170 ➝ GBX 1,990 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 9/24/2015 |
CCL Carnival Co. & | GBX 1,903.50
| 9/23/2015 | | Boost Price Target | GBX 3,600 ➝ GBX 3,800 | Buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 9/23/2015 |
WTB Whitbread | GBX 2,367 +0.8% | 9/15/2015 | | Lower Price Target | GBX 5,300 ➝ GBX 5,050 | Neutral | 00.00% | View details for Natixis rating of Whitbread (LON:WTB) on 9/15/2015 |
STM STMicroelectronics | $52.77 +1.6% | 9/14/2015 | | Lower Price Target | $10.50 ➝ $9.10 | Buy | 00.00% | View details for Natixis rating of STMicroelectronics (NYSE:STM) on 9/14/2015 |
GSK GSK | GBX 1,860 +0.5% | 9/9/2015 | | Lower Price Target | GBX 1,500 ➝ GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 9/9/2015 |
PSON Pearson | GBX 1,202.50 -1.3% | 9/3/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 9/3/2015 |
WATCH THIS BEFORE DECEMBER 8th!! (Ad) James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has noticed it.
Altucher believes the filing could matter to as many as 1,806,000 Americans in the years ahead. He explains why Musk buried it and what it could mean, free of charge. Watch the free breakdown before December 8th to learn more |
PSON Pearson | GBX 1,202.50 -1.3% | 8/13/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 8/13/2015 |
DGE Diageo | GBX 1,659.50 +1.2% | 6/26/2015 | | Reiterated Rating | GBX 2,170 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 6/26/2015 |
CCL Carnival Co. & | GBX 1,903.50
| 6/24/2015 | | Reiterated Rating | GBX 3,600 | buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 6/24/2015 |
PSON Pearson | GBX 1,202.50 -1.3% | 6/18/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 6/18/2015 |
VIVHY Vivendi | $1.63 +1.2% | 6/18/2015 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Vivendi (OTCMKTS:VIVHY) on 6/18/2015 |
FERG Ferguson | GBX 234.33
| 6/12/2015 | | Reiterated Rating | GBX 4,300 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 6/12/2015 |
DEO Diageo | $86.30 -1.4% | 6/9/2015 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Diageo (NYSE:DEO) on 6/9/2015 |
DGE Diageo | GBX 1,659.50 +1.2% | 6/9/2015 | | Upgrade | GBX 1,950 ➝ GBX 2,170 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 6/9/2015 |
PSON Pearson | GBX 1,202.50 -1.3% | 6/8/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 6/8/2015 |
HDELY Heidelberg Materials | $24.93
| 6/5/2015 | | Upgrade | | Reduce ➝ Neutral | 00.00% | View details for Natixis rating of Heidelberg Materials (OTCMKTS:HDELY) on 6/5/2015 |